Cargando…

Spontaneous and Engineered Compensatory HSV Mutants that Counteract the Host Antiviral PKR Response

A virulent recombinant HSV lacking the diploid γ(1)34.5 gene (Δγ(1)34.5) have been investigated over the last two decades both for anti-tumor therapy and as vaccine vectors. The first generation vectors, while safe, are incapable of sustained replication in the majority of treated patients. An inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Amish C., Parker, Jacqueline N., Shimamura, Masako, Cassady, Kevin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185541/
https://www.ncbi.nlm.nih.gov/pubmed/21994558
http://dx.doi.org/10.3390/v1030510